NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 829 filers reported holding NOVARTIS A G in Q1 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,848 | -98.9% | 194 | -98.9% | 0.00% | -100.0% |
| Q4 2022 | $1,584,788 | +49.5% | 17,469 | +25.3% | 0.00% | – |
| Q3 2022 | $1,060,000 | -1.2% | 13,946 | +9.8% | 0.00% | – |
| Q2 2022 | $1,073,000 | -5.5% | 12,699 | -1.9% | 0.00% | – |
| Q1 2022 | $1,136,000 | +780.6% | 12,951 | +825.1% | 0.00% | – |
| Q3 2015 | $129,000 | -6.5% | 1,400 | 0.0% | 0.00% | – |
| Q2 2015 | $138,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | +6.2% | 1,400 | 0.0% | 0.00% | – |
| Q4 2014 | $130,000 | -1.5% | 1,400 | 0.0% | 0.00% | – |
| Q3 2014 | $132,000 | +3.9% | 1,400 | 0.0% | 0.00% | – |
| Q2 2014 | $127,000 | +6.7% | 1,400 | 0.0% | 0.00% | – |
| Q1 2014 | $119,000 | +5.3% | 1,400 | 0.0% | 0.00% | – |
| Q4 2013 | $113,000 | +5.6% | 1,400 | 0.0% | 0.00% | – |
| Q3 2013 | $107,000 | -86.5% | 1,400 | -87.5% | 0.00% | -100.0% |
| Q2 2013 | $792,000 | – | 11,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |